TM Owner BioMarin
Palynziq 20mg/ml Injection
Global Shipping : Reliable Global Distribution Network
Express Delivery : Priority Shipping for Every Order
Secure Payments : Trusted Payment Protection System
Disclaimer
Secure Handling
24/7 Worldwide Support
Global Access
Worldwide Access to Health
Cold-Chain Expert
Excellence in Cold-Chain
Trusted Supply
Certified Medical Supply
Indications & Clinical Uses
- Palynziq (pegvaliase-pqpz) 20 mg/mL solution for injection contains pegvaliase, a PEGylated enzyme (phenylalanine ammonia lyase) that breaks down excess phenylalanine in the blood.
- It is indicated to lower blood phenylalanine levels in adults and adolescents aged 12 years and older with phenylketonuria (PKU) whose phenylalanine remains uncontrolled (generally above 600 micromol/L) despite existing dietary or medical management.
- It is not a cure for PKU and does not replace dietary phenylalanine restriction unless directed by a metabolic specialist; treatment is started and titrated slowly by a healthcare provider experienced in PKU management, because of the risk of serious allergic reaction described below.
- Palynziq carries a BOXED WARNING for anaphylaxis and is available only through the mandatory Palynziq REMS (Risk Evaluation and Mitigation Strategy) programme.
- It is given as a self-injection under the skin once the patient or caregiver has been trained, but only after the introductory dosing has been supervised in a healthcare setting.
Side Effects
- Very common reactions, each affecting 20% or more of patients in studies, include injection-site reactions, joint pain, hypersensitivity reactions, headache, generalised skin reactions, nausea, abdominal pain, vomiting, cough, sore throat, itching, diarrhoea, nasal congestion, tiredness and dizziness.
- Palynziq carries a BOXED WARNING for anaphylaxis: in clinical trials, about 10% of patients had at least one anaphylactic reaction, which can occur at any time during treatment, even after tolerating earlier doses, so every patient must carry auto-injectable epinephrine at all times and be trained to recognise and treat a reaction (facial or throat swelling, difficulty breathing, dizziness, widespread hives).
- Serious injection-site infections, including abscess, cellulitis or skin ulceration, have also been reported, so injection technique and site rotation matter.
- Seek emergency help immediately for any signs of a severe allergic reaction after a dose.
Precautions & Warnings
- Because of the BOXED WARNING for anaphylaxis, Palynziq is available only through the Palynziq REMS programme: prescribers and pharmacies must be certified, patients must be enrolled and counselled on anaphylaxis risk, and auto-injectable epinephrine must be available to the patient at all times.
- The first doses are given under direct healthcare supervision with observation for at least 60 minutes afterward before self-injection at home is considered.
- There are no absolute contraindications listed on the label, but caution and close monitoring are required in anyone with a history of hypersensitivity reactions.
- Aseptic injection technique and rotating injection sites reduce the risk of site infections.
- In pregnancy, Palynziq may cause fetal harm if phenylalanine levels are not kept in the target range (generally 120-360 micromol/L), so phenylalanine levels should be monitored closely throughout pregnancy; discuss the risks and benefits with a metabolic specialist before conceiving or if pregnancy occurs during treatment.
Avoid Interactions
- Palynziq should be used with added caution alongside other medicines or products containing polyethylene glycol (PEG), including certain injectable medroxyprogesterone acetate suspensions, because antibodies that develop against the PEG component of pegvaliase can increase the risk of a hypersensitivity reaction, including anaphylaxis, to these other PEGylated products.
- There is no established interaction with routine PKU dietary phenylalanine-restricted products, but any change in diet should be coordinated with the metabolic care team since it affects phenylalanine control alongside the medicine.
- Patients should tell every prescriber and pharmacist about their Palynziq treatment before starting any new medicine, including over-the-counter products, vaccines or supplements, particularly anything containing PEG.
- Do not mix Palynziq with other injectable drugs in the same syringe, and do not adjust the dose or injection schedule without guidance from the prescribing metabolic specialist.
References
Frequently Asked Questions
Palynziq (pegvaliase) lowers blood phenylalanine levels in people aged 12 and over with phenylketonuria (PKU) whose levels stay high despite existing treatment. It works by breaking down phenylalanine using an enzyme delivered by injection, alongside your usual PKU diet plan.
It is given as a subcutaneous (under the skin) injection, starting with small doses supervised by a healthcare provider and slowly increased over weeks to months. Once trained and tolerating it, most patients or caregivers self-inject at home, usually daily.
Palynziq carries a boxed warning for anaphylaxis, a severe allergic reaction that can happen at any time, even after earlier doses were tolerated - about 1 in 10 patients had this in trials. You must always carry auto-injectable epinephrine. Common effects include injection-site reactions, joint pain and headache.
Avoid other medicines containing polyethylene glycol (PEG), such as certain injectable contraceptive suspensions, since PEG antibodies from Palynziq can raise your risk of a reaction to them. Tell every healthcare provider you see that you take Palynziq before starting anything new.
Because of the anaphylaxis risk, Palynziq is dispensed only through the Palynziq REMS: prescribers and pharmacies must be certified, and you must be enrolled, trained to recognise anaphylaxis, and keep epinephrine auto-injectors with you at all times during treatment.
It can cause fetal harm if phenylalanine is not kept in the target range (generally 120 to 360 micromol/L), so levels must be monitored closely throughout pregnancy. Discuss pregnancy plans with your metabolic specialist before starting or continuing Palynziq.
Trusted & Reliable – Your Partner in Global Distribution.
We provide comprehensive lines of pharmaceutical products to support all your healthcare distribution needs.
